Columbus Life Sciences Fund V is a Valencia-based venture capital fund managed by Columbus Venture Partners. €220m reported at close (stage not stated) (source published June 2026).
Back early-identified technologies in longevity, European health manufacturing and supply chain, and clinically relevant AI.
Amounts come from the linked public source. A first close is not the final fund size, and a reported close does not confirm that the fund is investing now. Headquarters describe where the manager is based, not where it invests.